鈥淭here are only a few centres at the moment who could really give this drug effectively," says Professor Sir John Hardy (UCL Queen Square Institute of Neurology) about two new Alzheimer's drugs donanemab and lecanemab, adding that dementia care in the UK needs "a rethink."
, ,听
Close
